Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.
about
Regulation of ROCK activity in cancerSmall-molecule-induced Rho-inhibition: NSAIDs after spinal cord injuryThe RhoA-ROCK pathway in the regulation of T and B cell responsesThe atypical structure and function of newborn arterial endothelium is mediated by Rho/Rho kinase signalingProtection after stroke: cellular effectors of neurovascular unit integrity.ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.Rho/ROCK signaling in motility and metastasis of gastric cancerAssociation analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population.Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculationRho kinase as a therapeutic target in cardiovascular disease.Development of second-generation small-molecule RhoA inhibitors with enhanced water solubility, tissue potency, and significant in vivo efficacy.Anthrax lethal toxin-mediated disruption of endothelial VE-cadherin is attenuated by inhibition of the Rho-associated kinase pathwayInvestigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients.ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tensionFormononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway.Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in AtherosclerosisCentral Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progressionCigarette smoke inhibits ROCK2 activation in T cells and modulates IL-22 productionSuppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit.DL0805-2, a novel indazole derivative, relaxes angiotensin II-induced contractions of rat aortic rings by inhibiting Rho kinase and calcium fluxes.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion.Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Rho-kinase: important new therapeutic target in cardiovascular diseases.Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Rho-kinase: regulation, (dys)function, and inhibition.Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway.Rho Kinases and Cardiac Remodeling.In Development-A New Paradigm for Understanding Vascular Disease.Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.Effects of CC-chemokine receptor 5 on ROCK2 and P-MLC2 expression after focal cerebral ischaemia-reperfusion injury in rats.ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy.Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic NephropathyInhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysms
P2860
Q27006554-F0021C19-2B95-41B7-B5B5-80AB5AED8618Q27025964-126F4ADC-D066-4D67-95AB-18F96C4840BFQ28066137-61C482D5-AB09-46B3-8E71-C8814AAFE0DBQ28392632-C1DA175C-AB9B-4085-9D1C-CF8787300851Q34043168-C558DF50-B8C2-4FAE-A69C-6EAB6FFCF16FQ34109426-1426D8D4-7DAA-427E-AB52-EA405D9E244EQ34326599-1D303639-0455-4962-84ED-3C135C253DEEQ34551911-39B88752-93F0-4DDB-9E4C-1B24B495E3BAQ34797559-599B8FD0-83E9-432C-A9CB-6BFD8E032840Q34957350-D0980DCF-44EA-4D99-8889-87FA4230DA08Q35352722-2DD6C852-E0C3-4B45-A374-580278CE5B48Q35401180-9F31ECE5-333A-4BB7-9A8F-CC332FA1AFFAQ35534494-D933D726-3743-4EE5-B27F-D05E08EB6C1BQ35777721-EEB5A33F-E616-4CF2-A7D9-4DFBE8DF2CD4Q36164957-6F185A61-2EBD-43FD-9DEF-7C41DDAAD103Q36280985-6E19E174-04A0-4CA6-9198-0428A481DEE7Q36541529-C07A8578-D164-4CDF-97DD-AB5C8C56560DQ36612122-46325DB3-4F2A-4BC9-BFE3-BAF7F8450347Q36634247-A95883EA-8974-40C5-83E7-EA1EFD8B9EA8Q36701228-4EC7BC6F-A4E7-49E0-9F6A-99DEC27AD004Q36816542-E62BA008-FE80-48C9-8C0D-287FF280482AQ36872136-F3ED9A46-AF6A-4F45-9136-A8A1056C23DDQ36901827-1BAE793C-4B02-4D00-9E5B-7C50B8B7C314Q37122933-ABA5B82D-DA97-4C4B-8334-8A0205FC96DCQ37252129-78DBCBBD-22D6-4A20-AA09-3C19DC9816C6Q37312216-22068FBA-0D26-4F34-BA0B-968DAADC2CE6Q37334658-B647D7EF-0976-4965-BA40-B354F183859CQ37450106-6031AFAA-BE8C-4BD3-A945-022DBB47B0A1Q37881804-C30B9105-6FAE-4A78-979C-40D0CF9EE61CQ38101074-22E26260-FD48-4259-B599-05B27F14B138Q38129373-12128FBE-19C7-4428-9A59-7F7A96641CFAQ38181583-37120475-ACCE-4AE0-BDF0-ADA5EEA18060Q38802430-6B99BC29-314A-4DA5-9A89-38E720EAD0B2Q38850635-81221A7A-3D50-49FE-929D-4CBF7E756B6FQ39193273-262FB300-4250-4C04-9D46-0C99ED9C5EB5Q39206564-8EA29F56-5E5B-455D-9BE7-C810BA2997AAQ39915027-B1C5F4C9-9894-4547-870B-359721B3EFD8Q41458803-F7C6CBAF-A366-432F-800A-88C00242B257Q41574426-33DE762C-8F24-4FBB-8564-B464CAB6E5B6Q41994097-4E19913B-FD5E-4EFA-902B-3D5C885B0BDD
P2860
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@ast
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@en
Rho-associated coiled-coil-forming kinases
@nl
type
label
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@ast
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@en
Rho-associated coiled-coil-forming kinases
@nl
prefLabel
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@ast
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@en
Rho-associated coiled-coil-forming kinases
@nl
P2093
P2860
P1476
Rho-associated coiled-coil-for ...... clerosis and vascular disease.
@en
P2093
Christoph Gensch
James K Liao
P2860
P304
P356
10.1016/J.TIPS.2010.12.006
P577
2011-01-16T00:00:00Z